Plain-English translation of NCT04786262 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 1 research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing , a new cell-based treatment designed to help your body produce insulin naturally and prevent dangerous episodes of low blood sugar. If you have type 1 diabetes and have experienced severe low blood sugar episodes that you didn't see coming, this medication may help restore your awareness of when your blood sugar is dropping and reduce how often those dangerous episodes happen.
Many people with type 1 diabetes lose the ability to feel when their blood sugar is dropping dangerously low, which can lead to seizures, loss of consciousness, or other serious complications. This trial exists to see if the new treatment can help your body produce its own insulin and prevent these scary, unpredictable episodes.
You likely qualify if…
You likely don't qualify if…
You would receive an infusion of the new treatment and be monitored closely by the research team. You'll continue using your continuous glucose monitor throughout the study so the team can track how well the treatment is working to prevent low blood sugar episodes. The study involves regular clinic visits and follow-up appointments to check your safety and measure whether this medication is helping reduce severe hypoglycemia and restore your awareness of low blood sugar.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States